BRIEF published on 01/08/2026 at 18:05, 6 months 30 days ago Publication de la lettre aux actionnaires par Theranexus Actionnaires Médicaments Maladies Rares Theranexus Neurosciences
BRIEF published on 01/08/2026 at 18:05, 6 months 30 days ago THX Pharma Releases Shareholder Letter Drug Development Biopharmaceutical Shareholder Communication Neurological Diseases THX Pharma
BRIEF published on 01/08/2026 at 18:05, 6 months 30 days ago THX Pharma publie une lettre aux actionnaires Biopharmaceutique Communication Aux Actionnaires Développement De Médicaments Maladies Neurologiques THX Pharma
BRIEF published on 01/08/2026 at 18:05, 6 months 30 days ago Publication of the letter to shareholders by Theranexus Shareholders Neuroscience Rare Diseases Theranexus Drugs
PRESS RELEASE published on 01/08/2026 at 18:00, 6 months 30 days ago THX Pharma announces the publication of its letter to shareholders THX Pharma (Theranexus) announces the publication of its letter to shareholders, highlighting treatments for rare neurological diseases and upcoming drug commercialization. Forward-looking statements included Forward-looking Statements Theranexus Neurological Diseases THX Pharma Drug Commercialization
PRESS RELEASE published on 01/08/2026 at 18:00, 6 months 30 days ago THX Pharma annonce la publication de sa lettre aux actionnaires Theranexus annonce la publication de sa lettre aux actionnaires. THX Pharma se spécialise dans le traitement des maladies neurologiques rares. Plus d'infos sur leur site Actionnaires Newsletter Theranexus Maladies Neurologiques Rares THX Pharma
BRIEF published on 01/07/2026 at 08:05, 7 months 1 day ago THX Pharma appoints Julien Veys as Deputy General Manager Business Strategy Appointment THX Pharma Julien Veys Neurological Medications
BRIEF published on 01/07/2026 at 08:05, 7 months 1 day ago THX Pharma nomme Julien Veys au poste de directeur général adjoint Maladies Neurologiques Rares THX Pharma Nomination De Julien Veys Stratégie Theranexus Commercialisation Pharmaceutique
BRIEF published on 01/07/2026 at 08:05, 7 months 1 day ago THX Pharma Names Julien Veys as Deputy CEO Rare Neurological Diseases THX Pharma Julien Veys Appointment Theranexus Strategy Pharmaceutical Commercialization
BRIEF published on 01/07/2026 at 08:05, 7 months 1 day ago THX Pharma nomme Julien Veys au poste de Directeur général adjoint Nomination Stratégie Commerciale THX Pharma Julien Veys Médicaments Neurologiques
Published on 08/07/2026 at 23:15, 16 hours 14 minutes ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 16 hours 29 minutes ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 16 hours 59 minutes ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 17 hours 14 minutes ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/07/2026 at 23:21, 16 hours 8 minutes ago EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 19 hours 59 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 20 hours 14 minutes ago ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 21 hours 19 minutes ago Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request
Published on 08/07/2026 at 18:00, 21 hours 29 minutes ago E-PANGO: Composition du capital au 31 juillet 2026
Published on 08/07/2026 at 18:54, 20 hours 35 minutes ago Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 20 hours 35 minutes ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 20 hours 49 minutes ago Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 20 hours 49 minutes ago Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 21 hours 29 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026
